TABLE 2.

ELISPOT screening time pointsa

PatientELISPOT screenings (mo)HLA type
HLA-AHLA-BHLA-Cw
BR1112.5/5.5/7.5/19#/46.5#02/2344/4404/05
BR5542#/3.5#/7/11#/1902/3139/5107/15
BR14272/2.5/4#/14.5#26/2915/1502/03
03-322/9/26.501/0308/3504/07
  • ↵a Time points of ELISPOT screenings for CD8+-T-cell responses (at months posttransmission) are given, and visits that included ELISPOT screening of peptide-stimulated T-cell lines are marked (#). The patients’ HLA types are also indicated.